Cannabinoids Are the Next Big Thing in the Pot Industry, But Who Can Mass-Produce It?
It’s 2021 and regular THC isn’t going to cut it for the budding weed industry. Neither will CBD. Instead, a host of startups are betting that weed consumers will be clamoring for something that nature alone can’t provide.
!["The results reported here are very promising," the researchers wrote, "and indicate that CBD-enriched [cannabis] may ameliorate multiple [autism spectrum disorder] symptoms."](https://observer.com/wp-content/uploads/sites/2/2019/11/gettyimages-523205060.jpg?quality=80&crop=123px%2C0px%2C4003px%2C3001px&resize=300%2C225)
